Putnam Investments LLC Biomarin Pharmaceutical Inc Transaction History

Putnam Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $6,587 - $7,622	-76 Reduced 0.06%	134,954 $11.7 Million
Q1 2023 May 22, 2023	BUY	$87.74 - $117.27 $11.8 Million - $15.8 Million	135,030 New	135,030 $13.1 Million
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $121,963 - $222,357	-1,697 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $134,996 - $210,801	1,697 New	1,697 $210,000
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $73.1 Million - $85.4 Million	-909,552 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $21.2 Million - $24.9 Million	-252,267 Reduced 21.71%	909,552 $80.8 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $31.2 Million - $41.3 Million	389,551 Added 50.44%	1,161,819 $98.9 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $24.2 Million - $27.3 Million	258,110 Added 50.2%	772,268 $74.9 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $39.1 Million - $50.9 Million	514,158 New	514,158 $48.4 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.